Man-Mill Chemicals P Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.07 M
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.00 Cr
- Revenue Growth -74.34%
- Profit Growth -97.18%
- Ebitda -140.18%
- Net Worth 0.90%
- Total Assets -26.49%
About Man-Mill Chemicals P
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24110MH1993PTC075298
- Company No.
075298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 1993
- Date of AGM
21 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Man-Mill Chemicals P?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Shah  | Managing Director | 25-Nov-1993 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sonal Shah | Director | 25-Nov-1993 | Current |
Financial Performance of Man-Mill Chemicals P.
Man-Mill Chemicals P Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.34% decrease. The company also saw a substantial fall in profitability, with a 97.18% decrease in profit. The company's net worth moved up by a moderate rise of 0.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Man-Mill Chemicals P?
In 2023, Man-Mill Chemicals P had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novo Excipients Private LimitedGautam Shah and Sonal Shah are mutual person
G.C. Chemie Pharmie LimitedGautam Shah and Sonal Shah are mutual person
Emerald Leisures LimitedGautam Shah is a mutual person
Metaverse Pharmaceuticals Private LimitedGautam Shah and Sonal Shah are mutual person
- Vitamystic Healthcare Private Limited
Gautam Shah and Sonal Shah are mutual person
- Manmill Sciences Private Limited
Gautam Shah and Sonal Shah are mutual person
Charges (Loans)
₹0
₹10.00 Cr
Charges Breakdown by Lending Institutions
- Others : 8.00 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2021 | Others | ₹4.00 Cr | Satisfied |
| 17 Aug 2021 | Others | ₹5.00 M | Satisfied |
| 17 Aug 2021 | Others | ₹3.50 Cr | Satisfied |
| 22 Oct 2010 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.00 Cr | Satisfied |
How Many Employees Work at Man-Mill Chemicals P?
Unlock and access historical data on people associated with Man-Mill Chemicals P, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Man-Mill Chemicals P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Man-Mill Chemicals P's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
